Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn where to save for a house down payment with effective strategies. Make informed decisions for your financial future.
13,623 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
AI momentum is reshaping markets. This guide dives into what best artificial intelligence stocks to buy now, how to s...
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
Newmont, the largest gold miner, is facing a sell-off that’s drawing attention from traders and long-term investors a...
Alliant Energy Corp Stock is riding a bullish wave as three key drivers align: rising Midwest data-center demand, a d...
Georgia lawmakers have postponed plans to remove barcode voting from ballots, keeping QR-code systems in use and dela...
Two widely watched real estate ETFs take different paths to property exposure. This gqre icf: matchup real guide comp...
Got $10,000 and a goal to generate reliable cash from dividends? This guide shows how to pick the smartest dividend s...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A major logistics stock drops after a surprising accounting error, sending shockwaves through the market. This articl...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
A sudden disruption to helium from Qatar is reverberating through semiconductor and AI hardware supply chains. With Q...